CN Patent

CN101321527B — 治疗不正常细胞生长的方法

Assigned to Pfizer Products Inc · Expires 2012-05-30 · 14y expired

What this patent protects

本发明涉及一种新的c-Met/HGFR抑制剂即(R)-3-[1-(2，6-二氯-3-氟-苯基)-乙氧基]-5-(1-哌啶-4-基-1H-吡唑-4-基)-吡啶-2-基胺用于治疗哺乳动物体内不正常细胞生长的用途。更具体地说，本发明提供治疗患有癌症的哺乳动物的方法。

USPTO Abstract

本发明涉及一种新的c-Met/HGFR抑制剂即(R)-3-[1-(2，6-二氯-3-氟-苯基)-乙氧基]-5-(1-哌啶-4-基-1H-吡唑-4-基)-吡啶-2-基胺用于治疗哺乳动物体内不正常细胞生长的用途。更具体地说，本发明提供治疗患有癌症的哺乳动物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101321527B
Jurisdiction
CN
Classification
—
Expires
2012-05-30
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.